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Synopsis 
Lipoylation, the covalent attachment of lipoic acid to 2-oxoacid dehydrogenase multi-enzyme 
complexes, is essential for metabolism in aerobic bacteria and eukarya. In Escherichia coli, 
lipoylation is catalysed by lipoate protein ligase (LplA) or by lipoic acid synthetase (LipA) and 
lipoyl(octanoyl) transferase (LipB) combined. Whereas bacterial and eukaryotic LplAs comprise a 
single, two-domain protein, archaeal LplA function typically involves two proteins, LplA-N and 
LplA-C. In the thermophilic archaeon Thermoplasma acidophilum, LplA-N and LplA-C are 
encoded by overlapping genes in inverted orientation (lpla-c is upstream of lpla-n). The structure 
of Thermoplasma acidophilum LplA-N is known, but the structure of LplA-C and its role in 
lipoylation are unknown. We have determined the structures of the substrate-free LplA-N+LplA-C 
complex and the dihydrolipoyl acyltransferase lipoyl domain (E2lipD) that is lipoylated by LplA-
N+LplA-C, and carried out biochemical analyses of this archaeal lipoylation system. Our data 
reveal the following: LplA-C is disordered but folds upon association with LplA-N; LplA-C induces 
a conformational change in LplA-N involving substantial shortening of a loop that could repress 
catalytic activity of isolated LplA-N; the adenylate binding region of LplA-N+LplA-C includes two 
helices rather than the purely loop structure of varying order observed in other LplA structures; 
LplA-N+LplA-C and E2lipD do not interact in the absence of substrate; LplA-N+LplA-C 
undergoes a conformational change (the details of which are currently undetermined) during 
lipoylation; LplA-N+LplA-C can utilize octanoic acid as well as lipoic acid as substrate. The 
elucidated functional inter-dependence of LplA-N and LplA-C is consistent with their evolutionary 
co-retention in archaeal genomes. 
Key words: binding-induced folding, lipoate protein ligase, lipoyl domain, NMR spectroscopy, 
protein-protein interaction, X-ray crystallography 
Abbreviations used: BCOADHC, branched-chain 2-oxoacid dehydrogenase complex; CCD, 
charge coupled device; DSS, 2,2-dimethyl-2-silapentane-5-sulfonate, sodium salt; E1, 2-oxoacid 
decarboxylase; E2, dihydrolipoyl acyltransferase; E2lipD, dihydrolipoyl acyltransferase lipoyl 
domain; E3, dihydrolipoamide dehydrogenase; GCS, glycine cleavage system; HSQC, 
heteronuclear single-quantum coherence; IPTG, isopropyl β-D-1-thiogalactopyranoside; LA, 
lipoic acid; LipA, lipoic acid synthetase; LipB, lipoyl(octanoyl) transferase; LplA, lipoate protein 
ligase; LPT, LplA-like lipoyltransferase; MPD, 2-methyl-2,4-pentanediol; OADHC, 2-oxoacid 
dehydrogenase multi-enzyme complex; OA, octanoic acid; OGDHC, 2-oxoglutarate 
dehydrogenase complex; PDB, protein data bank; PDHC, pyruvate dehydrogenase complex; 
RMSD, root mean square deviation. 
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Introduction 
Aerobic metabolism of 2-oxoacids and C1 metabolism are dependent on lipoic acid (LA) in a 
highly conserved manner [1]. LA is an essential co-factor of the 2-oxoacid dehydrogenase 
complexes (OADHCs), which include the pyruvate (PDHC), 2-oxoglutarate (OGDHC) and 
branched-chain 2-oxoacid (BCOADHC) dehydrogenase complexes, and of the glycine cleavage 
system (GCS). OADHCs comprise multiple copies of three proteins: 2-oxoacid decarboxylase 
(E1), dihydrolipoyl acyltransferase (E2), and dihydrolipoamide dehydrogenase (E3). E2 
comprises E2 lipoyl domain(s) (E2lipD), a peripheral subunit-binding domain (PSBD), and a 
catalytic domain. E2lipD is the post-translational modification target: LA is covalently attached to 
E2lipD via an amide linkage to the ε-amino group of a specific lysine located at the tip of a β-turn. 
Once attached, the lipoyl moiety acts as a swinging arm that shuttles substrates/intermediates 
between the active sites of E1, E2 and E3. In the GCS, LA is attached to a lysine of the H protein 
that is structurally homologous to E2lipD. 
In Escherichia coli, E2lipD lipoylation is catalysed by lipoic acid synthetase (LipA) and 
lipoyl(octanoyl) transferase (LipB) or, if LA is present in the medium/environment, by lipoate 
protein ligase (LplA) [2-4]. LipB and LipA work in tandem: LipB catalyses the covalent attachment 
of octanoic acid (OA, derived from the fatty acid biosynthetic pathway) to E2lipD, and LipA 
introduces sulphur atoms at the C6 and C8 positions. LplA is typically a single polypeptide 
comprising an N-terminal domain (approximately 250 residues) that has an LA binding site, and 
a smaller C-terminal domain (approximately 90 residues) [5]. In E. coli and Oryza sativa, LplA 
can catalyse both steps of the lipoylation process: conversion of LA to lipoyl-AMP (lipoate 
adenylation) and subsequent covalent attachment of the lipoyl moiety to E2lipD (lipoate transfer) 
[6, 7]. Mammals achieve the equivalent process using two enzymes, lipoate activating enzyme 
and a LplA-like lipoyltransferase (LPT) [8]. In yeast, four enzymes are involved in lipoylation, 
including homologues of LipA, LipB and LplA, but there are major differences compared to 
lipoylation in E. coli [9]. Whilst LA metabolism in bacteria other than E. coli is not fully 
understood, details elucidated to date indicate that numerous variations exist [10-12]. 
Available structures include E. coli LplA [13] (PDB entries 1X2G, 1X2H, 3A7A, 3A7R), 
Streptococcal LplAs (PDB: 2P0L, 1VQZ) and a mammalian LPT [8] (PDB: 2E5A, 3A7U). LplA N-
terminal domain belongs to the α/β class of proteins [3, 5] and is structurally homologous and 
evolutionarily related to the central catalytic domain of biotin protein ligase and class II 
aminoacyl-tRNA synthetase [14, 15]. LplA C-terminal domain comprises three α-helices and two 
310-helices packed against a three-stranded β-sheet [5]. Bovine LPT resembles LplA in that it 
comprises a larger N-terminal domain and a smaller C-terminal domain, both with similar folds to 
their respective E. coli counterparts. The overall conformation of lipoyl-AMP-bound LPT is, 
however, stretched relative to unliganded E. coli LplA due to rotation of the C-terminal domain by 
about 180° with respect to the N-terminal domain [8]. A similar rotation of the C-terminal domain 
relative to its apo orientation was observed in the crystal structure of lipoyl-AMP-bound E. coli 
LplA [13]. In the same structure, it was noted that two important loops also undergo 
conformational change upon lipoate adenylation: the adenylate binding loop (residues 165-184), 
which is either partially disordered or not close to the active site in apo-LplA, covers the 
adenylate of lipoyl-AMP and interacts intimately with it, and the lipoate binding loop (residues 69-
76) is pulled towards lipoyl-AMP [13]. In the reaction scheme proposed by Fujiwara et al. [13], 
these conformational changes allow E. coli LplA to accommodate the lipoate acceptor 
domain/protein (E2lipD or H protein) and hence to catalyse the lipoate transfer step. These 
authors note, however, that in their LplA-apoH complex crystal structure with octanoyl-AMP 
rather than lipoyl-AMP, the distance between octanoyl-AMP and the acceptor lysine (LysApoH64) 
is too great for initiation of lipoyl transfer. In the same study, Fujiwara et al. also observed that, 
unlike E. coli LplA, bovine apo-LPT adopts the same relative N- and C-terminal domain 
orientations as lipoyl-AMP-bound LPT [13]. 
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Archaeal LplA studies have been conducted largely in Thermoplasma acidophilum, a species 
that possesses genes encoding individual proteins that resemble the N- and C-terminal domains 
of non-archaeal LplA. We term these gene products LplA-N and LplA-C. Structures of T. 
acidophilum LplA-N in unliganded (PDB: 2ARS and 2C7I), lipoyl-AMP-bound (PDB: 2ART), lipoic 
acid-bound (PDB: 2C8M), and ATP-bound (2ARU) forms exhibit the same overall fold as the 
non-archaeal LplA N-terminal domain [3, 16]. It was shown in crystal soaking experiments (one 
day soaks) that LplA-N can catalyse lipoate adenylation to form lipoyl-AMP [16], but LplA-N is 
unable to catalyse lipoate transfer in vitro and an accessory protein was suggested [3]. We 
subsequently showed that LplA-N requires LplA-C to carry out lipoylation (corroborated using 
complementation assays in E. coli [17]) and that lipoylation occurs in vivo [18]. 
Comparative genomic analyses across 115 archaeal genomes (Dorus, Bagby et al, Syracuse 
University and University of Bath, unpublished data) show that archaeal species capable of 
lipoylation retain either the LplA or LipA-LipB system with 81% (61 of 75 species) retaining LplA. 
Despite the evolutionary predominance of LplA in the archaea, and the fact that LplA-C is 
essential for lipoate transfer, no mechanistic information exists concerning coordination of LplA-N 
and LplA-C function. Here we have used structural and biochemical methods to investigate the 
role of LplA-C. We present structures of the T. acidophilum LplA-N+LplA-C complex and of 
E2lipD, show that LplA-C folding is driven by association with LplA-N and that LplA-C induces 
localised conformational change in LplA-N, and use NMR to monitor LplA-N+LplA-C interactions 
with lipoic acid/ATP and E2lipD, and to monitor E2lipD lipoylation. 
Experimental 
Expression and purification of T. acidophilum LplA-N+LplA-C and T. acidophilum E2lipD. 
pET19b-lpla and pET24a-ctd [18] were co-transformed into E. coli BL21(DE3) and expression 
was induced with 0.25 mm IPTG at 16°C overnight. Harvested cells were sonicated, the lysate 
was centrifuged at 21000 g for 40 min and LplA-N+LplA-C complex was purified using His 
MultiTrap™ FF and His MultiTrap™ HP columns (GE Healthcare Life Sciences, Amersham, UK). 
The final LplA-N+LplA-C complex purity was >95% as judged by SDS-PAGE. T. acidophilum 
E2lipD was expressed and purified as described previously [18]. 
Expression and purification of E. coli LplA and E2lipD. E. coli LplA and E2lipD were 
expressed using TM202 and pET11c plasmids. Expression in BL21(DE3) was induced with 0.5 
mM IPTG for 3 h at 37°C. Cells were sonicated and proteins were purified using HiTrap QFF with 
a 0-0.5 M NaCl gradient in 20 mM Tris-HCl, pH 7.5. 
Crystallization of T. acidophilum LplA-N+LplA-C complex, data collection and structural 
analysis. T. acidophilum LplA-N+LplA-C was exchanged into 10 mM Tris-HCl, pH 7.5, 
concentrated to 20 mg/ml and centrifuged at 13000 g for 20 min at 4°C. Sitting drop, vapour 
diffusion crystallization screens were set up at 18°C using Molecular Dimensions screens with a 
Phoenix robot (Art Robbins Instruments, Sunnyvale, California). Crystals in 40 % (v/v) MPD, 0.1 
M sodium acetate (pH 4.6), and 0.02 M CaCl2 were suitable for X-ray diffraction without further 
cryo-protectant. Diffraction data were collected at Diamond Light Source (Oxon, UK) on an 
ADSC Q315 CCD detector on station IO2 (λ = 0.9795 Å). 360 images were collected at an 
oscillation angle of 1°. Raw data images were processed using HKL2000 [19]. 
Model building. Molecular replacement using BALBES [20] was followed by model building with 
Coot [21] and rounds of refinement using Refmac5, part of CCP4 [22]. Other software included 
Molprobity [23] and Procheck [24]. 
Structural analysis. Hydrogen bonds and ionic interactions were evaluated with Contact CCP4 
[22], ProtorP [25] and PISA [26]. Molecular graphics figures were prepared in PyMOL (The 
PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC). 
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NMR spectroscopy. 15N-labelled LplA-C and 15N- and 15N13C-labelled E2lipD were produced by 
expression in M9 minimal medium supplemented with 1 g/L 15NH4Cl as the sole nitrogen source 
or 1 g/L 15NH4Cl and 2 g/L 13C glucose, respectively. His-tagged proteins were purified as 
described previously [18]. Most E2lipD and all LplA-N+LplA-C NMR data were acquired at 37°C 
or 50°C on a 600 MHz Varian Unity INOVA spectrometer with an ambient temperature probe, 
processed using NMRPipe/NMRDraw [27] and analyzed using CCPN Analysis [28]. 15N-edited 
NOESY and 13C-edited NOESY spectra of E2lipD were acquired on an 800 MHz Varian Inova 
spectrometer at the MRC Biomedical NMR Centre, Mill Hill. 1H, 15N and 13C chemical shifts were 
referenced to DSS [29]. Structures were calculated as described previously [30]. 1H-15N HSQC 
spectra of uniformly 15N-labelled LplA-C, both with and without unlabelled LplA-N, were recorded 
in 20 mM Tris pH 7.5, 150 mM NaCl. E2lipD spectra were recorded in 50 mM HEPES pH 7.5, 50 
mM NaCl. All 1H-15N HSQC spectra in this study were recorded with 128 increments in the 
nitrogen dimension, unless otherwise stated. 
NMR titration of LplA-N+LplA-C with lipoic acid, ATP and Mg2+, then with E2lipD. Lipoic 
acid (racemic mixture unless stated otherwise), ATP and Mg2+ were titrated in combination 
against an NMR sample containing LplA-N+LplA-C (unlabelled LplA-N and uniformly 15N-labelled 
LplA-C) in 20 mM Tris pH 7.5, 150 mM NaCl. The molar ratio of LplA-N+LplA-C to lipoic acid at 
each titration point was 1:0, 1:0.25, 1:0.50, and 1:1.25; a 1H-15N HSQC spectrum (32 scans, 128 
min recording time) was recorded at each titration point. Unlabelled E2lipD was then added to 
the same NMR sample with ratios of LplA-N+LplA-C to E2lipD of 1:0.25, 1:0.50, and 1:1.25; a
1H-15N HSQC spectrum (32 scans, 128 minutes recording time) was recorded after each E2lipD 
addition. 
NMR titration of LplA-N+LplA-C with E2lipD, and then with lipoic acid, ATP and Mg2+. 
Unlabelled E2lipD was added to an NMR sample containing LplA-N+LplA-C (unlabelled LplA-N 
and uniformly 15N-labelled LplA-C with no lipoic acid/ATP/Mg2+) in 20 mM Tris pH 7.5, 150 mM 
NaCl. The molar ratio of LplA-N+LplA-C to E2lipD at each titration point was 1:0, 1:0.25, 1:0.50, 
1:0.75, and 1:1; a 1H-15N HSQC spectrum (24 scans, 160 increments, 120 min recording time) 
was recorded at each titration point. Lipoic acid (2 mM), ATP (2.5 mM) and Mg2+ (1 mM) were 
then added together; a 1H-15N HSQC spectrum (24 scans, 160 increments) was recorded both 
directly after this addition and on the following day after overnight storage at 4 °C. 
NMR titration of E2lipD with LplA-N+LplA-C, lipoic acid, and ATP. Catalytic quantities of 
LplA-N+LplA-C were added to 15N-labelled 1.1 mM E2lipD in four steps (molar ratio of E2lipD to 
LplA-N+LplA-C of 1:0.0025, 1:0.005, 1:0.0075 and 1:0.01), followed by two additions of lipoic 
acid to a final concentration of 2.25 mM, and then by two additions of ATP to a final 
concentration of 2.25 mM (1.5 mM Mg2+ was present in initial NMR sample). A 1H-15N HSQC 
spectrum was recorded at each titration point (8 scans, 34 min recording time). Chemical shift 
perturbations were calculated as a weighted average of 1H and 15N chemical shift changes, Δδav 
(Δδav (ppm) = [(Δδ2HN + Δδ2N/25)/2]1/2) [31]. 
Lipoylation/octanoylation activity assay. The electrophoretic mobility of E2lipD before and 
after lipoylation/octanoylation was analysed by non-denaturing PAGE as described previously 
[18]. In the lipoylation/octanoylation assays and T. acidophilum/E. coli enzyme cross-reactivity 
assays, the ratio of lipoylated to non-lipoylated E2lipD was quantified by mass spectrometry. 
Synthesis of octanoyl-AMP. This was carried out as described previously [32, 33]. 
Model of LplA-N+LplA-C:E2lipD complex. In order to model a possible end-point of 
conformational change in LplA-N+LplA-C that permits lipoylation of E2lipD, the relative 
orientation of LplA-N and LplA-C was first changed to that observed between the N- and C-
terminal domains of E. coli LplA in its complex with apo H protein and octanoyl-AMP (PDB: 
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3A7A). E2lipD was then docked with the reoriented LplA-N+LplA-C complex using ClusPro 2.0 
[34, 35]; in the resulting models, E2lipD orientation and acceptor lysine (Lys E2lipD42) position 
were compared to those in 3A7A of apo H protein and LysApoH64 respectively. Models 
comparable to 3A7A (i.e. with Lys E2lipD42 in proximity to and oriented towards the LplA-N active 
site) were selected and their quality assessed using QMean [36]. The model from this subset 
with the highest QMean score was selected as a representative structure. 
PDB accession codes. Coordinates and structure factor file for theT. acidophilum LplA-N+LplA-
C structure and coordinates for the E2lipD structures are in the Protein Data Bank (PDB) under 
accession codes 3R07 and 2L5T. 
Results 
Structure of T. acidophilum LplA-C. Despite the fact that LplA-C is essential for lipoylation by 
archaeal LplA [17, 18], the functional and structural relationship between LplA-N and LplA-C is 
poorly understood. We examined whether LplA-N and LplA-C exist independently or form a 
stable complex by first studying LplA-C structure without LplA-N. In crystallization screens, LplA-
C showed a high propensity to precipitate. Poor chemical shift dispersion, variable peak intensity, 
and low peak count (approximately 50 peaks observed versus 84 expected based on the LplA-C 
amino acid sequence) in 1H-15N HSQC NMR spectra showed that LplA-C is disordered and 
heterogeneous over a range of pH values (pH 6-8) and NaCl concentrations (50-150 mM NaCl) 
(Figure 1A). Upon stepwise addition of unlabelled LplA-N to 15N labelled LplA-C (final LplA-
N+LplA-C molar ratio of 1:1), the observed dramatic increase in dispersion, homogeneity and 
number of LplA-C 1H-15N HSQC peaks indicates that LplA-C undergoes LplA-N binding-induced 
folding (Figure 1B). Seventy-six distinct backbone amide NH peaks were observed in the LplA-N-
bound LplA-C 1H-15N HSQC spectrum; this close correspondence with the expected total of 84 
peaks indicates that LplA-N-bound LplA-C adopts a single dominant conformation on average, 
and indirectly supports the presence of a single predominant LplA-N+LplA-C complex 
conformation in solution. The LplA-N-induced LplA-C fold, and by inference the LplA-N+LplA-C 
complex, is stable to at least 50°C (Figure 1B). 
Figure 1 1H-15N HSQC NMR spectra of T. acidophilum LplA-C in the absence and presence of LplA-
N. (A) 1H-15N HSQC spectrum at 37°C recorded on uniformly 15N-labelled LplA-C by itself and (B) in a 1:1 
molar ratio with unlabelled LplA-N; an overlay of 1H-15N HSQC spectra recorded at 37°C (blue) and 50°C 
(red) is shown. 
T. acidophilum LplA-N+LplA-C X-ray crystal structure: comparison with other LplAs. 
Subsequent to the LplA-C NMR studies described above, crystallization screens of co-expressed 
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LplA-N and LplA-C produced LplA-N+LplA-C complex crystals in 40% (v/v) MPD, 0.1 M sodium 
acetate (pH 4.6), 0.02 M CaCl2. The LplA-N+LplA-C structure (Figure 2A) was determined to 2.7
Å resolution by molecular replacement with LplA-N (PDB: 2ARS) (Table 1). The overall fold of 
LplA-N [3, 16] is maintained in the presence of LplA-C, as confirmed using Dali [37] (Table 2). 
The β-strands in LplA-N are β1 (residues 1-7), β2 (35-39), β3 (44-47), β4 (68-71), β5 (79-81), β6 
(85-93), β7 (121-123), β8 (128-131), β9 (144-154), and β10 (157-165); the α-helices are α1 (13-
27), α2 (59-65), α3 (98-117), α4 (181-183), α5 (184-194), α6 (206-223), α7 (232-246), and α8 
(249-254); and the 310- or η-helices are η1 (52-56), η2 (171-176) and η3 (198-202). The β-
strands in LplA-C are β11 (2-10), β12 (15-23), and β13 (26-35), and the α-helices are α9 (42-52), 
α10 (58-68), and α11 (79-86), where the LplA-C strand and helix numbering continues from the 
LplA-N numbering but the residue numbers start anew at the LplA-C N-terminus. 
LplA-N+LplA-C is structurally similar to single polypeptide apo-LplAs from Streptococcus 
pneumoniae and E. coli, including similar domain orientations (Figure 2C; Table 2). Bovine (Bos 
taurus) LPT, however, has a different arrangement of domains in both apo and lipoyl-AMP-bound 
forms, as does lipoyl-AMP-bound E. coli LplA; in these cases, the C-terminal domain has 
undergone a 180° rotation (Figure 2C) [13]. The structures of E. coli LplA C-terminal domain and 
T. acidophilum LplA-C agree well, with both forming a canopy above the tunnel-like entry to the 
active site. With respect to the inverted gene orientation in T. acidophilum (lpla-c is upstream of 
lpla-n with a TATA box upstream of lpla-c but no cis-regulatory sequence in the proximity of lpla-
n) [18], it is important to note that the LplA-C C-terminus and LplA-N N-terminus are located at
opposite ends of the LplA-N+LplA-C complex, approximately 56 Å apart (Figure 2A), confirming 
that LplA-N and LplA-C are made as separate polypeptides. 
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Figure 2 Structure of the T. acidophilum LplA-N+LplA-C complex. (A) LplA-N (green) and LplA-C 
(blue). Secondary structure elements, and the LplA-N N-terminus and LplA-C C-terminus, are indicated. 
(B) Some of the ionic interaction and hydrogen bond network interactions (indicated by dashed lines) 
between LplA-N (green) and LplA-C (blue) with side chains in pale yellow (different orientation of the 
complex to that in A). (C) Overlays of unliganded/apo T. acidophilum LplA-N+LplA-C (PDB: 3R07), E. coli 
LplA (PDB: 1X2G) and S. pneumoniae LplA (PDB: 1VQZ) (left) and of lipoyl-AMP bound E. coli LplA 
(PDB: 3A7R) and bovine LPT (PDB: 3A7U) (right). The N-terminal domain orientation is the same in 
both overlays. 
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A. Crystallographic data 
Resolution (Å) 2.7 
Space group P3121 
Unit cell parameters 
a = b (Å) 118.57 
c (Å) 72.92 
α = β (°) 90 
γ (°) 120 
B. Merging statistics 
No. of reflections 15063 
Average redundancy 7.1 (7.1) 
I/σI 37.1 (6.1) 
Completeness (%) 96.0 (98.5) 
R-merge (%) 7.7 (43.2) 
C. Refinement statistics 
RMSD bond length (Å) 0.015 
RMSD bond angle (°) 1.547 
Residues in disallowed regions (%) 0 
Mean B value (Å2) 51.561 
R-factor (%) 19.8 
R-free (%) 25.4 
Table 1 Data collection and structural refinement statistics. Numbers in parentheses represent statistics at
the highest resolution (2.7-2.8 Å). 
Organism Ligands PDB 
code 
Dali search 
with 2ARS; 
Z-score 
(RMSD, Å) 
Dali search with 
T.acidophilum LplA-
N+LplA-C; 
Z-score (RMSD, Å) 
T. acidophilum None 2ARS 45.3 39.1 (0.6) 
None 2C7I 43.2 (0.7) 38.2 (0.7) 
Lipoic acid 2C8M 43.2 (0.7) 
ATP 2ARU 44.12 (0.3) 38.9 (1.0) 
Lipoyl-AMP 2ART 44.12 (0.5) 38.9 (1.0) 
S. pneumoniae None 1VQZ 26.7 (2.5) LplA-N: 26.9 (2.8) 
LplA-C: 11.4 (1.5) 
E. coli None 1X2G LplA-N: 25.9 (2.8) 
LplA-C: 8.8 (2.3) 
Lipoic acid 1X2H LplA-N: 25.4 (2.9) 
LplA-C: 8.7 (2.3) 
Lipoyl-AMP 3A7R LplA-N: 28.5 (2.2) 
LplA-C: 9.7 (2.1) 
Octanoyl-
AMP, ApoH 
3A7A LplA-N: 28.5 (2.3) 
LplA-C: 9.7 (2.1) 
Bos taurus 2E5A LplA-N: 27 (2.1) 
LplA-C: 7.7 (2.5) 
Table 2 Summary of Dali similarity searches. The values as determined for T. acidophilum LplA-N and 
LplA-C are listed individually and have been obtained from pairwise Dali comparisons. 2ARS was 
compared only with the most similar non-T. acidophilum LplA, which is S. pneumoniae LplA (PDB: 1VQZ). 
The LplA-N+LplA-C interface has a buried surface area of 805 Å2 compared to 993 Å2 between 
the N- and C-terminal domains of the closest single protein homologue, S. pneumoniae LplA [3, 
18]. The LplA-N+LplA-C interface involves 50 residues and includes 12 hydrogen bonds plus five 
salt bridges involving three pairs of residues [26]. These include a five-residue network that 
forms salt bridges (GluLplA-N56-ArgLplA-C17, GluLplA-N55-HisLplA-C31) and four hydrogen bonds 
(GluLplA-N55-HisLplA-C31, GluLplA-N55-SerLplA-C33, GluLplA-N56-ArgLplA-C17) (Figure 2B). In the 
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corresponding location, S. pneumoniae LplA has an inter-domain three-residue (Arg45-Asp284-
His46) network with two inter-domain ionic interactions involving Asp284, and E. coli LplA has no 
obvious ionic interaction. In addition, the LplA-N+LplA-C interface has a substantial hydrophobic 
component with about 25 hydrophobic residues contributing to the interface. 
LplA-C-induced conformational change of LplA-N: “capping” loop and adenylate binding 
loop. LplA-N undergoes a substantial local structural rearrangement upon binding LplA-C. In 
isolated LplA-N (i.e. without LplA-C), β8 consists of residues 138-141 and is connected to β9 
(residues 144-154) by a short β-turn, while strands β7 and β8 are connected by a long loop 
consisting of residues 124-137 (orange and labelled as the “capping loop” in Figure 3). 
Interestingly, this loop makes several contacts with lipoyl-AMP in 2ART, and may play a role in 
ensuring that isolated LplA-N is catalytically inert. This region is reorganized in the LplA-N+LplA-
C structure such that residues 128-131 form β8, and a short turn comprising residues 125-127 
connects β7 to β8, while β8 is connected to β9 by a disordered loop comprising residues 132-
142, for most of which electron density is not observed (Figure 3). This structural shift seems to 
be facilitated by the similarity of the two motifs that alternate as β8 - residues 128-131 are DVSI, 
while residues 138-141 are DIMA. It is noteworthy that in E. coli LplA, β8 is a fixed motif, 
connected to β7 and β9 by short loops on either side. 
The lipoate binding loop adopts the same conformation with and without LplA-C (Figure 3), 
whereas in LplA-N+LplA-C a substantial portion of the region corresponding to the adenylate 
binding loop strikingly forms contiguous α-helices (α4 and α5; residues 181-183 and 184-194). In 
other LplA structures, this region is either a loop or is largely disordered such that electron 
density is absent. In several structures of isolated LplA-N, for example, much of the adenylate 
binding loop region is disordered (e.g. 2ARS, 2C7I – both unliganded, 2C8M – lipoic acid bound, 
2ART – lipoyl-AMP bound), although it is noteworthy that following an electron density gap in the 
structures 2ARS, 2ART and 2C8M, there is a nascent α-helix that overlaps with part of LplA-
N+LplA-C α5 (e.g. region shown in purple in Figure 3). In the structure of unliganded E. coli LplA 
(1X2G), the adenylate binding loop occupies a similar position to LplA-N+LplA-C helices 
α4 and α5, whereas there is again missing electron density in unliganded bovine LPT. The 
adenylate binding loops of lipoyl-AMP bound E. coli LplA and bovine LPT overlap closely with 
each other and are shifted towards the active site relative to the adenylate binding loops of the 
respective unliganded enzymes. 
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Figure 3 LplA-C-induced conformational change of LplA-N. The structure of the LplA-N+LplA-C 
complex (3R07) is shown with LplA-N predominantly in grey and LplA-C in blue. The structure of isolated 
(i.e. without LplA-C) LplA-N (2ART) is superimposed on the LplA-N+LplA-C complex and is also shown 
predominantly in grey. Structural features of 3R07 are highlighted in green and structural features of 2ART 
are highlighted in yellow, orange and purple. Lipoyl-AMP from 2ART is shown in red. Secondary structure 
elements of 3R07 are labelled. The lipoate binding loop conformations are almost identical in 3R07 (green) 
and 2ART (yellow). In the absence of LplA-C, residues 124-137 form a long loop (orange – labelled as 
“capping loop”); the corresponding loop (green) is much shorter in the LplA-N+LplA-C complex. Instead, 
the subsequent loop is much longer in the LplA-N+LplA-C complex than in isolated LplA-N (electron 
density is lacking between V133 and G142 in the LplA-N+LplA-C complex). Residues identified by 
structure-based alignment to form the adenylate binding region are shown in green (3R07) and purple 
(2ART), although in 2ART much of the adenylate binding region lacks defined electron density. 
LplA-N+LplA-C interaction with lipoyl-AMP and E2lipD. We used NMR titrations to 
investigate LplA-N+LplA-C interactions, monitoring the 1H-15N HSQC spectrum of 15N-labelled 
LplA-C in complex with unlabelled LplA-N. In one titration (Titration 1), lipoic acid, ATP and Mg2+ 
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were added together to LplA-N+15N-LplA-C, then E2lipD was added (Figure 4A and 4B). Upon 
addition of lipoic acid, ATP and Mg2+ (and presumably therefore upon formation of the lipoyl-
AMP-bound form of LplA-N+LplA-C), fifteen of the seventy-six distinct backbone amide NH 
peaks in the 1H-15N HSQC spectrum of LplA-N+15N-LplA-C were significantly broadened 
(intermediate timescale exchange), five exhibited slow exchange (two peaks observed per 
backbone amide NH), four underwent a chemical shift change, four exhibited both chemical shift 
change and broadening, and at least one peak increased significantly in intensity (Figure 4A). 
Upon subsequent titration of E2lipD into the LplA-N+15N-LplA-C NMR sample, most of the peaks 
that had been perturbed (Figure 4A) reverted to a state the same as or close to that observed 
prior to addition of lipoic acid, ATP and Mg2+ (Figure 4B), consistent with lipoyl transfer to E2lipD 
and hence consumption of substrate. 
In a separate titration (Titration 2), unlabelled E2lipD was first titrated into a LplA-N+15N-LplA-C 
NMR sample to a final molar ratio of 1:1 LplA-N+LplA-C to E2lipD, producing essentially no 
change in the LplA-N+15N-LplA-C 1H-15N HSQC spectrum. Significant perturbation of the 1H-15N 
HSQC was observed, however, when lipoic acid, ATP and Mg2+ were then added (Figure 4C): at 
least thirty peaks underwent chemical shift change, five peaks were broadened, three showed 
both broadening and chemical shift change, one showed chemical shift change plus increased 
intensity, and two new peaks appeared in the vicinity of an initially absent peak at around 8.8 
ppm, 116.3 ppm that is generally weak/absent in LplA-N+15N-LplA-C 1H-15N HSQC spectra. 
Notably, at least 75% of the peaks perturbed in Titration 1 were also perturbed in Titration 2. 
When a 1H-15N HSQC spectrum was recorded the next day on the same sample, some peaks 
had reverted towards a pre-lipoic acid/ATP/Mg2+ position/intensity, but some had not (Figure 4D). 
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Figure 4 1H-15N HSQC spectra of LplA-N+15N-LplA-C: titration with lipoic acid, ATP and Mg2+, and 
with E2lipD. The results of two titrations are shown. In (A) and (B), lipoic acid, ATP, and Mg2+ were added 
before E2lipD. In (C) and (D), E2lipD was added before lipoic acid, ATP and Mg2+. (A) Lipoic acid, ATP 
and Mg2+ were added together in step-wise fashion to an NMR sample containing LplA-N+LplA-C 
(unlabelled LplA-N and uniformly 15N-labelled LplA-C) in 20 mM Tris, pH 7.5, 150 mM NaCl. A 1H-15N 
HSQC spectrum was recorded at each titration point. The molar ratio of LplA-N+LplA-C complex to lipoic 
acid at each titration point was 1:0, 1:0.25, 1:0.50, 1:1.25. The initial spectrum is shown in blue, the final 
spectrum in yellow. LplA-C peaks perturbed upon addition of lipoic acid, ATP and Mg2+ are highlighted as 
follows: intermediate exchange (broadening) - solid rectangle; slow exchange (two peaks) - broken line 
rectangle; chemical shift change – solid ellipse; chemical shift change and broadening - broken line ellipse; 
increase in intensity – blue broken line rectangle. (B) E2lipD was then added to the same NMR sample as 
(A) with molar ratios of LplA-N+LplA-C to E2lipD of 1:0.25, 1:0.50, 1:1.25. The final spectrum is shown in 
red with the same peaks highlighted as in (A). Most of the peaks perturbed in (A) reverted to the pre-lipoic 
acid/ATP/Mg2+ state, which is again represented by blue peaks. (C) In the second titration, E2lipD was 
added in four steps (molar ratio of LplA-N+LplA-C to E2lipD at each titration point was 1:0, 1:0.25, 1:0.50, 
1:0.75, and 1:1) with essentially no change in the LplA-C 1H-15N HSQC spectrum (not shown). Lipoic acid 
(2 mM), ATP (2.5 mM) and Mg2+ (1 mM) were then added together. The spectrum after E2lipD addition is 
shown in blue, and the spectrum after lipoic acid, ATP and Mg2+ addition is shown in yellow. Perturbed 
LplA-C peaks are highlighted using the same scheme as in (A), except that some of the larger chemical 
shift changes are indicated by an arrow (dotted line arrow where the connection between the shifted peak 
and the original peak is tentative), newly appearing peaks are indicated by a blue dashed rectangle, and 
chemical shift change plus increased intensity is indicated by a blue dashed ellipse. The peak at around 
6.4 ppm, 113 ppm labelled with an asterisk moved to 6.1 ppm, 113 ppm. Peaks subject to smaller 
chemical shift changes have not been highlighted. (D) 1H-15N HSQC spectrum of the same sample as in 
(C), recorded after leaving the sample overnight at 4 °C. 
Substrate promiscuity and recognition of E2 lipoyl domains by LplA-N+LplA-C. As its 
bipartite nature may affect substrate recognition and specificity, we tested T. acidophilum LplA-
N+LplA-C activity with different acceptor domains and substrates, including LA, OA and 
octanoyl-AMP, with E. coli LplA serving as a positive control. In gel shift lipoylation assays [18] 
with LA, co-expressed LplA-N+LplA-C and a 1:1 mixture of individually expressed and purified 
LplA-N and LplA-C showed equal activity. LplA-N+LplA-C showed activity with both OA and 
octanoyl-AMP, in agreement with previous findings that LplAs can catalyse the formation and 
transfer of octanoyl-AMP [38]. As judged by mass spectrometry, E2lipD modification efficiency by 
LplA-N+LplA-C with OA substrate was 20-30% of that with LA substrate. 
E2lipD cross-reactivity was analysed next. E2lipD residues both N-terminal (-) and C-terminal (+) 
of the target lysine are important for efficient lipoylation [39]. Previous large-scale sequence 
alignments identified a highly conserved Asp(-1), hydrophobic residues at +1, +5 and -4, Glu/Asp 
enrichment at -3 and +4, and Ser/Ala at +7 [40]. Glu(-3) and Gly(-16) are involved in LplA 
recognition. Sequence alignment with E. coli E2lipDs and E. coli H protein shows that Gly(-16) is 
conserved in T. acidophilum E2lipD. Glu(-3) is conserved in E. coli E2lipDs and H protein, 
whereas T. acidophilum E2lipD has Met(-3); residues other than Glu at -3 reduce lipoylation 
efficiency in E. coli [41]. Correspondingly, E. coli LplA lipoylated T. acidophilum E2lipD with about 
50% efficiency relative to E. coli E2lipD, and T. acidophilum LplA-N+LplA-C lipoylated E. coli 
E2lipD with about 15-20% efficiency relative to T. acidophilum E2lipD. 
NMR analysis of T. acidophilum E2lipD structure and lipoylation. In order to facilitate 
modelling studies of the complete T. acidophilum lipoylation system (see below), T. acidophilum 
E2lipD structure was determined by NMR. T. acidophilum E2lipD is similar overall to other lipoyl 
domains (DaliLite Z-score of 6.8 and r.m.s.d. over all Cα atoms of 2.7 Å versus E. coli E2lipD 
(PDB:1QJO; 27% sequence identity)). In an NMR titration to monitor E2lipD lipoylation, T. 
acidophilum E2lipD 1H-15N HSQC did not change upon step-wise addition of catalytic quantities 
of LplA-N+LplA-C (final molar ratio 100 E2lipD: 1 LplA-N+LplA-C), nor upon addition of LA (final 
molar ratio approximately 1 E2lipD: 2 LA) (Figure 5). Upon subsequent addition of ATP (final 
molar ratio approximately 1 E2lipD: 2 ATP), however, several E2lipD backbone amide peaks 
underwent chemical shift perturbation (Figures 5A and 5B); the largest chemical shift 
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perturbations were observed for E2lipD residues 42-44 (Lys E2lipD42 is the lipoylation target 
residue), followed by residues 9-10; the ThrE2lipD40 peak was broadened. When mapped onto the 
E2lipD structure, the pattern of largest chemical shift perturbations (plus broadening for residue 
40) indicates that lipoylation induces a localized conformational change in E2lipD (Figure 5C). 
Total number of NOE restraints 
intraresidue 
sequential/med. range (i to i+1⎯ 4) 
long range 
648 
146 
270 
232 
Number of dihedral angle restraints 76 
Number of hydrogen bond restraints 12 
Rmsd for backbone atomsa 0.48 Å 
Rmsd for non-hydrogen atomsa 1.11 Å 
Average number of NOE violations
>0.5Å (per structure) 
0 
Average number of dihedral angle violations 
>1o (per structure) 
4 
Ramachandran plot statisticsb 
Most favoured (%) 
Additional allowed (%) 
Generously allowed (%) 
Disallowed (%) 
81.4 
15.2 
3.2 
0.1 
Table 3 Structural statistics for the ensemble of NMR-derived structures of E2lipD. a The rmsd from the 
mean structure calculated over residues 2-5, 16-20, 27-29, 37-39, 44-46, 53-58, 64-66, 73-76.b Calculated 
with PROCHECK-NMR. 
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Figure 5 Chemical shift perturbation upon lipoylation of E2lipD. (A) Overlaid 1H-15N HSQC spectra of 
uniformly 15N-labelled E2lipD from titration of 15N-labelled 1.1 mM E2lipD with catalytic quantities of LplA-
N+LplA-C in four steps (molar ratio of E2lipD to LplA-N+LplA-C of 1:0.0025, 1:0.005, 1:0.0075 and 1:0.01), 
followed by two additions of lipoic acid to a final concentration of 2.25 mM; the final spectrum from the 
titration to this point is shown in green (no change from original spectrum). ATP was then added to a 
concentration of 2.25 mM; the subsequent 1H-15N HSQC spectrum is shown in red. Peaks are labelled 
with amino acid assignments (assignments could not be made for E11, G12, T14, E30, Y60 and T71 due 
to lack of peaks in 3D spectra; unlabelled backbone NH peaks are assumed to arise from these residues 
or from the N-terminal 6His-tag residues; the G16 peak (1H and 15N chemical shifts of 8.22 ppm and 
104.75 ppm, respectively) is omitted to allow greater overall clarity. Peaks showing the largest chemical 
shift changes upon addition of ATP are highlighted with an ellipse drawn around the pre-ATP (green) and 
post-ATP (red) peak positions (the peak due to T40 was broadened out of the spectrum upon E2lipD 
lipoylation). (B) Lipoylation-induced chemical shift changes (calculated using Δδav (ppm) = [(Δδ2HN + 
Δδ2N/25)/2]1/2) plotted as a function of E2lipD residue number. ∗ indicates an unassigned residue, P 
indicates a proline residue (proline does not produce a signal in 1H-15N HSQC spectra), and B indicates a 
peak that was broadened out of the spectrum upon E2lipD lipoylation. Red = Δδav (ppm) ≥ 0.1 ppm, orange 
= Δδav (ppm) ≥ 0.04 ppm, and yellow = Δδav (ppm) ≥ 0.02 ppm. E2lipD secondary structure elements (β-
strands) are indicated by arrows above the histogram. (C) E2lipD surface with most of the residues 
perturbed upon lipoylation highlighted using the same colour scheme as in (B). 
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Model of T. acidophilum LplA-N+LplA-C:E2lipD complex. In E. coli LplA, lipoate adenylation 
causes conformational changes, including 180º rotation of the C-terminal domain (Figures 2C 
and 6A), that prime the system for lipoyl transfer [13]. In T. acidophilum apo-LplA-N+LplA-C, 
LplA-C forms a canopy over the active site in a similar manner to the C-terminal domain of other 
LplAs, obstructing access to lipoate of LysE2lipD42, the lipoate acceptor residue (Figure 6A). 
Hence, a substantial change to the apo-LplA-N+LplA-C structure is required for lipoylation to 
occur. Using E. coli LplA:octanoyl-AMP:ApoH protein complex crystal structure as a template 
([13]; Figure 6A), we have modelled a possible end-point of such a change with E2lipD 
incorporated (Figure 6B). The respective lipoate acceptor residues (T. acidophilum LysE2lipD42 
and E. coli LysApoH64) are in similar positions (Figure 4B). In our model, E2lipD bridges LplA-N 
and LplA-C, and LplA-C has undergone a rotation of approximately 120º. Thirty-five LplA-N 
residues, 8 LplA-C residues, and 34 E2lipD residues are involved in the interface (24). 
Figure 6 Lipoate protein ligase complexes with E2lipD or ApoH protein. (A) Superposition of E. coli 
octanoyl-5’-AMP-bound LplA (yellow) in complex with E. coli ApoH (grey) (PDB: 3A7A) and T. acidophilum 
LplA-N (green)+LplA-C (blue) (PDB: 3R07). (B) Comparison of the acceptor lysine residue positions in the 
E. coli LplA:ApoH complex and in the T. acidophilum LplA-N+LplA-C:E2lipD complex in which LplA-C has 
undergone a change in position and orientation relative to LplA-N+LplA-C. E. coli ApoH is positioned as in 
the LplA:ApoH complex but E. coli LplA has been omitted for clarity. The lipoyl acceptor residue of E. coli 
ApoH, LysApoH64, is shown in black. T. acidophilum E2lipD is in magenta with its lipoyl acceptor residue, 
LysE2lipD42, in cyan. Octanoyl-5’-AMP (red) is positioned as in the E. coli LplA:ApoH complex. 
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Discussion 
Biochemical data from our laboratory and elsewhere indicate that LplA-C is essential for 
lipoylation of E2 in T. acidophilum [17, 18], although LplA-N by itself can catalyse lipoate 
adenylation to form lipoyl-AMP [16]; it is still not clear, however, whether LplA-C enhances 
catalysis of lipoate adenylation, although it is known to be essential at least for lipoate transfer. 
Our genomic profiling, moreover, indicates that bipartite LplA-N+LplA-C is the evolutionarily 
predominant lipoylation system in the archaea. Despite these observations, structural and 
mechanistic information on LplA-C function has been lacking. The structures of T. acidophilum 
LplA-N+LplA-C and E2lipD presented here represent the first structural analysis of a complete 
archaeal lipoylation system and the first of a bipartite lipoate protein ligase. The structure of LplA-
N was already known [3, 16], but the nature of LplA-N association with the functionally essential 
LplA-C was unknown [17, 18]. It was not clear, for example, whether LplA-C is always associated 
with LplA-N or only during lipoylation. We now know that LplA-C is probably not functional by 
itself as it is disordered and undergoes LplA-N-induced folding. The C-terminal domain of E. coli 
LplA, on the other hand, was found by limited proteolysis to be structurally stable [3]. We do not 
know, however, whether LplA-C retains its fold once it is released from LplA-N as we have been 
unable to establish a non-denaturing procedure to dissociate the LplA-N+LplA-C complex. 
The current evidence indicates that the observed interface between LplA-N and LplA-C is a 
biological rather than crystal packing interface and that LplA-N and LplA-C exist permanently as 
a complex. This evidence includes the observations that isolated LplA-C is disordered, the LplA-
N+LplA-C complex is stable to at least 50 °C (Figure 1), LplA-N and LplA-C associate strongly 
upon co-expression, there is an extensive buried hydrophobic surface between LplA-N and LplA-
C, similar interfaces are observed in other LplA structures from several organisms, and LplA-N 
and LplA-C are functionally inter-dependent. There are thus mechanistic differences from the 
LipA-LipB system in which LipA and LipB operate sequentially, although we note that E. coli LipA 
and LipB have been found to form a tight non-covalent association with the E2 components of 
PDHC and OGDHC [4], presumably with resulting potential for greater processivity and for 
interaction between LipA and LipB themselves. The inherent robustness of T. acidophilum LplA, 
and presumably LplA from other thermophiles, makes these ligases attractive starting points for 
biotechnological and chemical biology applications such as have been demonstrated for E. coli 
LplA [42, 43]. 
The T. acidophilum LplA-N+LplA-C complex adopts the same fold and the same spatial 
arrangement of domains as the structurally characterised bacterial apo-LplAs (PDB: 1X2G, 
2P0L, 1VQZ; Figure 2). LplA-N+LplA-C does, however, possess at least two distinctive local 
conformational features that could be functionally important. Firstly, in E. coli LplA and bovine 
LPT, the adenylate binding region is a loop, often at least partially disordered, whereas in LplA-
N+LplA-C the equivalent region includes two contiguous α-helices (α4 and α5; Figure 3). We 
cannot say whether these helices persist at the optimum temperature (55 °C) for T. acidophilum, 
but their presence reduces the probability that the LplA-N adenylate binding region undergoes 
the same transition as the E. coli adenylate binding region upon lipoate adenylation which 
includes formation of a new β-strand anti-parallel to β13 of the C-terminal domain [13]. Secondly, 
LplA-C-induced conformational changes in LplA-N around strands β7 and β8 result in substantial 
shortening of a loop (that we label as the capping loop in Figure 3) that in isolated LplA-N 
partially occupies the space that the adenylate binding loop occupies in E. coli LplA. It is likely 
that the capping loop functions at least to repress catalytic activity of LpA-N in the absence of 
LplA-C. It would be interesting in future to establish whether replacement of the capping loop 
with the equivalent short loop from E. coli LplA shows gain of function effects in isolated LplA-N. 
E. coli LplA undergoes significant structural changes upon lipoate adenylation, including 
reorientation of the C-terminal domain to produce a more stretched overall conformation (PDB: 
3A7R). Bovine LPT adopts this stretched domain arrangement in both apo- and lipoyl-AMP-
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bound forms (PDB: 2E5A, 3A7U). We have been unable to produce crystals of LplA-N+LplA-C 
complexes with lipoyl-AMP and with E2lipD that diffract to sufficient resolution to investigate 
structural changes in LplA-N+LplA-C. We have, however, studied LplA-N+LplA-C interactions 
with lipoic acid/ATP/Mg2+ and E2lipD using 1H-15N HSQC NMR spectra, which are highly 
sensitive to conformational changes and interactions. We did two titrations in which at each step 
we recorded 1H-15N HSQC spectra of 15N-labelled LplA-C in complex with unlabelled LplA-N. In 
Titration 1, lipoic acid/ATP/Mg2+ were added before E2lipD such that lipoate adenylation and 
lipoate transfer are monitored separately. The observed NMR spectral changes (Figure 4A) are 
not immediately suggestive of a substantial LplA-C conformational change upon formation of the 
lipoyl-AMP intermediate, but a LplA-C positional change like the 180° rotation of the C-terminal 
domain observed in E. coli LplA [13] cannot be ruled out as the observation of exchange in about 
25 peaks indicates that nearly a third of LplA-C residues sample more than one chemical 
environment. 
In Titration 2, E2lipD was added before lipoic acid/ATP/Mg2+. The lack of change upon E2lipD 
addition indicates that in apo-LplA-N+LplA-C, LplA-C does not interact with E2lipD and further, if 
there is any E2lipD interaction with LplA-N in apo-LplA-N+LplA-C, it does not occur in the vicinity 
of LplA-C. Chemical shift perturbations were observed in more than a third of LplA-C 1H-15N 
HSQC peaks when lipoic acid/ATP/Mg2+ were then added to the mixture of apo-LplA-N+LplA-C 
and E2lipD (Figure 4C). Thus a more substantial change in LplA-C occurs when E2lipD is 
already present at the time of adding lipoate adenylation ingredients. A reliable explanation of 
this observation would require extensive further investigation, but for now we note that lipoate 
adenylation and lipoate transfer are monitored simultaneously in Titration 2, rather than 
separately as in Titration 1. We note also that at least 75% of peaks perturbed in Titration 1 were 
also perturbed in Titration 2, indicating the involvement of substantially overlapping regions of 
LplA-C in any conformational/positional changes occurring during the two titrations. 
Our NMR data, particularly from Titration 2, indicate that LplA-C does undergo significant 
conformational change at one or more stages of lipoylation. This is consistent with our structure-
based hypothesis that rearrangement of the LplA-N+LplA-C complex, akin to that seen in E. coli 
LplA [13], is required to allow E2lipD access to the LplA-N active site and hence to allow lipoate 
transfer. In our model of a possible end-point of such a rearrangement, LplA-C has rotated 
through approximately 120º, compared to the approximately 180º rotation observed for E. coli 
LplA C-terminal domain upon lipoate adenylation [13]. One potential flaw in our model, in 
common with the E. coli LplA:octanoyl-AMP:ApoH protein complex crystal structure, is that the 
distance between the adenylated intermediate and the acceptor lysine (LysE2lipD42) is too great 
for initiation of lipoyl transfer. It remains to be seen whether, as Fujiwara et al suggest [13], this is 
rectified if a version of a LplA-E2lipD/H protein complex with “true substrates” can be crystallised. 
Assuming that LplA-C becomes disordered if it is released from LplA-N, there is no evidence 
from our NMR data that LplA-C dissociates from LplA-N during lipoate adenylation or lipoate 
transfer; we detect only folded LplA-C species during catalysis of both steps, suggesting that 
LplA-C is not competed off LplA-N by incoming substrate and that LplA-C remains bound to 
LplA-N during any rearrangement of the complex. There remains the possibility, however, of 
minor populations of disordered LplA-C species at any one time that are not detected by the 
techniques used here. On the other hand, if LplA-C remains structured upon dissociation from 
LplA-N, then rearrangement of the LplA-N+LplA-C complex could clearly involve a simple 
release and rebind mechanism. 
We also used NMR to monitor the effect of lipoylation on E2lipD. We believe that the observed 
chemical shift perturbations upon addition of the lipoylation ingredients (Figure 5) are more likely 
to result from lipoylation-induced localised conformational change in E2lipD than from non-
covalent E2lipD interaction with LplA-N+LplA-C (present only in catalytic quantities) or substrate. 
Previous NMR analysis did not indicate any conformational change in E2lipD from Bacillus 
stearothermophilus PDHC upon lipoylation [44]. The reason for the difference is not obvious, but 
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it is clear that the results of this titration represent further evidence that the T. acidophilum LplA-
N+LplA-C complex is functional. 
We have previously described features of the genes encoding LplA-C and LplA-N, including the 
facts that their genes overlap by a single base pair, and a TATA box is readily identifiable 
upstream of lpla-c; however, no cis-regulatory sequence is observed in the proximity of lpla-n, 
suggesting that the genes are transcriptionally coupled. Given that the gene order is lpla-c then 
lpla-n [18],  our structure-based observation that the LplA-C C-terminus and LplA-N N-terminus 
are located at opposite ends of the LplA-N+LplA-C complex confirms that LplA-N and LplA-C are 
made as separate polypeptides. 
We have shown that, like other LplAs, T. acidophilum LplA-N+LplA-C can utilize OA and 
octanoyl-AMP as substrates, albeit less efficiently than LA. At first glance this may be 
unsurprising, but fatty acid synthesis, the source of the OA precursor, is thought to be absent in 
the archaea [45]. It has long been hypothesized that ancient enzyme promiscuity gave rise to the 
specialized enzyme activities known today [46]. Hence, the ability to utilize OA as well as LA may 
reflect an early evolutionary state. Notably, this promiscuity has a physiological advantage in E. 
coli where LipB mutants can still carry out lipoylation using LipA and LplA [38]. LplA is 
evolutionarily related to LipB and biotin protein ligase [14] but whether LplA may have served as 
an evolutionary platform for LipB or vice versa is uncertain. 
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